乳腺癌治疗与舒张功能障碍：在心脏肿瘤学中我们是否应担忧心脏舒张功能？ - Suppr

Breast Cancer Treatment and Diastolic Dysfunction: Should We Worry About Relaxing in Cardio-Oncology?

作者信息

Thavendiranathan Paaladinesh, Calvillo-Argüelles Oscar

机构信息

Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

出版信息

JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):211-214. doi: 10.1016/j.jcmg.2019.07.022. Epub 2019 Sep 18.

DOI:10.1016/j.jcmg.2019.07.022

PMID:31542544

Abstract

摘要

相似文献

Breast Cancer Treatment and Diastolic Dysfunction: Should We Worry About Relaxing in Cardio-Oncology?

JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):211-214. doi: 10.1016/j.jcmg.2019.07.022. Epub 2019 Sep 18.

Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.

Eur J Heart Fail. 2019 Apr;21(4):529-535. doi: 10.1002/ejhf.1385. Epub 2019 Feb 27.

The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines ± Trastuzumab: a Meta-analysis of clinical studies.

Crit Rev Oncol Hematol. 2020 Sep;153:103006. doi: 10.1016/j.critrevonc.2020.103006. Epub 2020 May 22.

Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.

J Am Soc Echocardiogr. 2015 May;28(5):509-14. doi: 10.1016/j.echo.2015.02.001. Epub 2015 Mar 13.

Trastuzumab Cardiotoxicity After Anthracycline Exposure Constitutes a Complex and Clinically Important Entity.

JACC Heart Fail. 2019 Sep;7(9):805-807. doi: 10.1016/j.jchf.2019.04.012. Epub 2019 Aug 7.

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.

Breast Cancer Res Treat. 2017 Nov;166(1):241-247. doi: 10.1007/s10549-017-4362-x. Epub 2017 Jul 14.

Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.

JACC Cardiovasc Imaging. 2018 Aug;11(8):1084-1093. doi: 10.1016/j.jcmg.2018.06.005.

Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.

Echocardiography. 2016 Apr;33(4):519-26. doi: 10.1111/echo.13168. Epub 2016 Mar 16.

Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.

Oncologist. 2015 Jun;20(6):605-14. doi: 10.1634/theoncologist.2014-0299. Epub 2015 May 1.

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer.

Breast Cancer Res Treat. 2011 Dec;130(3):845-54. doi: 10.1007/s10549-011-1714-9. Epub 2011 Sep 15.

引用本文的文献

Analysis of Cardiotoxicity and Risk Factors of Breast Cancer Chemotherapy Drugs: A Five-Year Single-Centre Retrospective Study in Early Breast Cancer.

Drug Des Devel Ther. 2025 Jul 30;19:6505-6517. doi: 10.2147/DDDT.S516457. eCollection 2025.

Synthetic generation of cardiac tissue motion from surface electrocardiograms.

Nat Cardiovasc Res. 2025 Apr;4(4):445-457. doi: 10.1038/s44161-025-00629-x. Epub 2025 Apr 14.

Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma.

Cardiooncology. 2022 Nov 15;8(1):18. doi: 10.1186/s40959-022-00145-y.

Role of Oxidative Stress in the Mechanisms of Anthracycline-Induced Cardiotoxicity: Effects of Preventive Strategies.

Oxid Med Cell Longev. 2021 Jan 25;2021:8863789. doi: 10.1155/2021/8863789. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Breast Cancer Treatment and Diastolic Dysfunction: Should We Worry About Relaxing in Cardio-Oncology?

作者信息

Thavendiranathan Paaladinesh, Calvillo-Argüelles Oscar

机构信息

Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

出版信息

JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):211-214. doi: 10.1016/j.jcmg.2019.07.022. Epub 2019 Sep 18.

DOI:10.1016/j.jcmg.2019.07.022

PMID:31542544

Abstract

摘要

相似文献

Breast Cancer Treatment and Diastolic Dysfunction: Should We Worry About Relaxing in Cardio-Oncology?

JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):211-214. doi: 10.1016/j.jcmg.2019.07.022. Epub 2019 Sep 18.

Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.

Eur J Heart Fail. 2019 Apr;21(4):529-535. doi: 10.1002/ejhf.1385. Epub 2019 Feb 27.

The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines ± Trastuzumab: a Meta-analysis of clinical studies.

Crit Rev Oncol Hematol. 2020 Sep;153:103006. doi: 10.1016/j.critrevonc.2020.103006. Epub 2020 May 22.

Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.

J Am Soc Echocardiogr. 2015 May;28(5):509-14. doi: 10.1016/j.echo.2015.02.001. Epub 2015 Mar 13.

Trastuzumab Cardiotoxicity After Anthracycline Exposure Constitutes a Complex and Clinically Important Entity.

JACC Heart Fail. 2019 Sep;7(9):805-807. doi: 10.1016/j.jchf.2019.04.012. Epub 2019 Aug 7.

Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.

Breast Cancer Res Treat. 2017 Nov;166(1):241-247. doi: 10.1007/s10549-017-4362-x. Epub 2017 Jul 14.

Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.

JACC Cardiovasc Imaging. 2018 Aug;11(8):1084-1093. doi: 10.1016/j.jcmg.2018.06.005.

Echocardiography. 2016 Apr;33(4):519-26. doi: 10.1111/echo.13168. Epub 2016 Mar 16.

Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.

Oncologist. 2015 Jun;20(6):605-14. doi: 10.1634/theoncologist.2014-0299. Epub 2015 May 1.

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer.

Breast Cancer Res Treat. 2011 Dec;130(3):845-54. doi: 10.1007/s10549-011-1714-9. Epub 2011 Sep 15.

引用本文的文献

Analysis of Cardiotoxicity and Risk Factors of Breast Cancer Chemotherapy Drugs: A Five-Year Single-Centre Retrospective Study in Early Breast Cancer.

Drug Des Devel Ther. 2025 Jul 30;19:6505-6517. doi: 10.2147/DDDT.S516457. eCollection 2025.

Synthetic generation of cardiac tissue motion from surface electrocardiograms.

Nat Cardiovasc Res. 2025 Apr;4(4):445-457. doi: 10.1038/s44161-025-00629-x. Epub 2025 Apr 14.

Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma.

Cardiooncology. 2022 Nov 15;8(1):18. doi: 10.1186/s40959-022-00145-y.

Role of Oxidative Stress in the Mechanisms of Anthracycline-Induced Cardiotoxicity: Effects of Preventive Strategies.

Oxid Med Cell Longev. 2021 Jan 25;2021:8863789. doi: 10.1155/2021/8863789. eCollection 2021.

Breast Cancer Treatment and Diastolic Dysfunction: Should We Worry About Relaxing in Cardio-Oncology?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Breast Cancer Treatment and Diastolic Dysfunction: Should We Worry About Relaxing in Cardio-Oncology?

作者信息

机构信息

出版信息

相似文献

引用本文的文献